Labcorp SVP, Chief Accounting Officer Peter J. Wilkinson Disposes of 1,420 Shares Worth $439,103.37

Labcorp Holdings Inc. Stock Rises Tuesday, Still Underperforms Market

Labcorp Holdings is Maintained at Neutral by Piper Sandler

Piper Sandler Adjusts Price Target on Labcorp Holdings to $309 From $300, Maintains Neutral Rating

Labcorp Launches FDA-Approved Pten Companion Diagnostic for Prostate Cancer

Labcorp : JP Morgan Raises Target Price to $360 from $330

UBS Remains a Buy on Labcorp Holdings (LH)

Labcorp Holdings is Maintained at Buy by Truist Securities

Labcorp Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Fulgent Genetics Q2 Revenue Rises 20% Sequentially, Sees Billing System Transition Delay

CareDx Q2 Revenue Beats Estimates; Outlook Lifted

Barclays Raises Labcorp Price Target to $320 From $290, Maintains Equalweight Rating

U.S. Stocks on the MOVE-Mastercard, Starbucks, Meta

Labcorp Releases Transcript of Q2 2026 Earnings Call Webcast Prepared Remarks

Labcorp Exec Says Specialty Testing Business Continues to Grow Faster than Routine Testing Business, Expects Trend to Continue - Conf Call

Labcorp Exec Says Oncology Patients Tend to Receive Significantly More Tests over Time than Typical Patients, Driving Higher Tests Per Accession - Conf Call

Labcorp Exec Says Assumption for About 30 Basis Points Impact to 2026 Diagnostics Volume from Aca-Related Changes Remains Appropriate - Conf Call

Stock Track | Labcorp Holdings Plunges 5.43% in Pre-market as Diagnostics Revenue Miss Weighs on Strong Q2 Results

Labcorp Raises Annual Profit Forecast on Strong Testing Demand

Labcorp Lifts Outlook as 2Q Profit, Revenue Rise